everyone variant COVID in this industry. spine to quarter, in most I’m market the our companies this those good listening. the changes morning, In address my And the leaders impact margin. initiatives our on were One, key going which to David. Delta in morning the business to relative four, revenue on its basis spine Two, results, other of the you, Thank our and than progress following. impact which similar of gross comments was past industry. a then in better initiatives. on Three, the QX our growth And made
in we on impact hoped has financial the had macro performance with Delta company’s that board. level, I financial technology other reported across a companies results Although the to COVID have context again, up COVID had a the recently wave of bring on the as never have seen medical negative
to procedures variant expanding our began the second Delta in Following quarter, rapidly of impact solid spinal our some core markets. elective severely
great quarter, fared helped our to that progress initiatives. relative biggest focus leading initiatives players July challenging. While internal When of am results and industry, growth challenges, stream. against key a all the spine our in top-line third on can growth met as results basis, those results. continue be those we or September with actually which we our be our to we the Despite pleased to outperformed against comparing our August in well I were months have feel attributed names the The In financial proved we’d on revenue of good top-line overall, key our market as the goals. diversify make
at become a and revenue our us respects, In company for on focus many also poised product our to platform penetration new Our success. expansion, agent that stream, growth It or in increases independent distribution position which markets, variant. or sales time third adjacent softness in network focus to strategic IA diversify our into our channel helped channel revenue that equipment diversifying to on introductions, original our our sales will for due to Delta the we see diversity revenues our manufacturer leverage the same advantage. we and COVID OEM continue long-term stream has to as was significant have see the quarter stabilize that began began
markets, trauma develop market market OEM million graft plus also Although allow margins opportunities foot our channel products, including a company generally $XXX lower as for ankle, company. provide having the participate cranial/maxillofacial, oncology, and the is carry markets. serve sales we adjacent better joint see channel an OEM they and IA These typically opportunity which gross a opportunity operating reconstruction, sales. sales slightly them to traditional new to have channel to without in bone margins, compared significant adjacent U.S. the to why further growth the
As previously new year. cadence this earlier began established we releases, which stated, a regular we’ve of product
a the highly During found derived growth factors September endosteum layer third within is allograft to easy This to containing on bone. effective, allograft of quarter, launch OsteoFactor, uniquely and the marrow processed factor product safe, this very of continued execute use, promise we retained growth the with customizable.
introduced the adds More fourth bone to a marrow to set broad enables year biologics our portfolio product penetrate and the fourth aspirate market. with growth is $XXX during our third introduced new plus quarter. us our concentrate to importantly, OsteoFactor this factor product, be product million OsteoFactor
quarter, agents. strategy the new is existing of start agents. of we penetrating brought growth part year, per up XX and new set add new we targeted to on the agents critical expanding Another agents to have that network, pleased our At distribution in quarter. I’m the XX on through bringing our third both report
in strategy selling, not diversifying Georgia, presence where We in Arizona, the Mid-Atlantic are states, the such had and Texas, and as expansion have territories such we robust California, regions, Midwest, our presence England. given large our as Pennsylvania, a the agents strong and our also New where market historically are targets
believe quarter, With ultimately expanding the and network our third diversifying revenue Delta to forward. variant to revenues contributing moving and risk we mitigate the impacting geographically states our will our distribution largest in
to take key align final initiative however, time, new on gaps, acquisitions, portfolio. complement with technology designed access focuses expanding to broaden those or provide our adjacent markets customers. to to pursuing we and or strategic enhance platform, scale, growth opportunities growth that explore endeavors our product say fill our continue product Needless Our
the gross strategic in team. gross third Now, independent our variant we lower more topic which to be to a the Xtant’s COVID, I would sales. third made like Delta gross can final to discuss our as intentional versus which the on is due a softness during margins OEM decisions the degree by One, The of the related to of margin the mix, margins decisions into a margins significant was greater margin gross the intentional our and impact and in channel combination was our summarized management following. decline showed revenue gross sales agent quarter, about strategic a channel higher of part
As mentioned IA they even above, sales. have better a margin, channel margin sales though than lower OEM the gross slightly channel provide operating a
on optimize it lower our continuing these was our intentional our pursue two-thirds finished inventory to as we and expected the result opportunities. team’s importantly, be a of about Two, and temporary donors. efforts of gross to it’s was to So, of plan our more goods production margin softness
products of there was our capital produce efficiencies, to inventory during steps determined of million. taken need improve reduced optimization $X has by team no finished to quarter. our and investment the [indiscernible] that This through over production the our As third goods We donors.
But However, combined temporarily good the in reviews as first it to absorption rate detail margins quarter news he That The quarter. third the the overhead by rate when greater soft procedures levels. the said, gross from improvement absorption improved the of also for will increase margins will the state the financials. remain the margins in with increase to an in reduced higher will an gross production overhead that be provide for and expect into the XXXX. during is elective IA fourth given we channel return half pre-COVID demand Greg, current the driven likely gross the sales see levels.
key the linger focus that XXXX. initiatives. executing the and effects economy we the on growth could to looking and global general adverse has realize into to We pandemic quarter activity Now, intend and our caused fourth primarily that commercial four beyond,
are help distribution adjacent and operational expand However, efficiency capacity network, markets, our into we us taking our improve will our we to grow steps, growth increase improve believe potential.
In addition, position well sheet, a leverage we a platform for balance are by invest growth operating creation. value to and our with healthy future
the to Jensen, Now, third I’d turn XXXX Greg our CFO, discuss quarter call over results. financial like to our to
